Digest Network Come funziona
Network
/
Società
Co
Non verificato

Cosette Pharmaceuticals, Inc.

Di cosa scriviamo

FarmaceuticaMercato azionarioSalute

7 comunicati stampa

Guarda tutti i comunicati
16/12/2025
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
11/12/2025
Mercato azionario
Salute
Farmaceutica
Termination of Proposed Acquisition of Mayne Pharma
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
30/06/2025
Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
20/02/2025
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/02/2025
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
03/02/2025
Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/07/2024
Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0